-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Ultragenyx Pharmaceutical Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2012 to 2023.
- Ultragenyx Pharmaceutical Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $8.85M, a 68.9% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual Depreciation, Depletion and Amortization for 2023 was $26M, a 42.7% increase from 2022.
- Ultragenyx Pharmaceutical Inc. annual Depreciation, Depletion and Amortization for 2022 was $18.2M, a 37.6% increase from 2021.
- Ultragenyx Pharmaceutical Inc. annual Depreciation, Depletion and Amortization for 2021 was $13.2M, a 7.98% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)